Pay Versus Performance
We break down the details for boards and management teams.
Taking the next steps
Pearl Meyer's team of strategic consultants and technical experts have been thinking ahead and mapping out exactly how the SEC's move affects clients. We offer advice and guidance on pay vs. performance with multiple viewpoints, helping boards and management teams get ready for this disclosure and understand what it does and does not mean.
Our Client Alerts and Guiding Webcast
Pay Versus Performance Rules Finalized and Effective for Next Proxy Season
After 13 years and much debate, the SEC has finalized its guidance for one of the most complex executive compensation disclosures required under the Dodd-Frank Act.
Pay Versus Performance is Here: What Compensation Committees Must Do Now
How companies can take immediate action to collect the information and create the narratives around this data-heavy requirement.
Decoding the SEC’s Updates on Pay Versus Performance Rules
We outline the new information to take into account as companies draft PVP disclosures, and note which issues remain open for imminent filers.
Special Considerations and Novel Thinking About PVP
The Reader’s Guide to Pay Versus Performance
Members of our Technical Services team share thoughts on how they suggest reading the new PvP disclosures and interpreting the data.
Pay Versus Performance Watch: The First Filers
PVP disclosure data and trends based on this year’s first 60 public filings.
The SEC Just Kicked CD&A Drafting Season into High Gear
Given the new pay versus performance rules, drafting this year’s CD&A will be an especially heavy lift. Here’s how to get started now.
Pay vs. Performance: What Do Public Company Directors Need to Know?
Management may bear the heavy burden when it comes to the new disclosure, but there are key points boards must understand and discuss this fall.
Navigating Dodd-Frank Disclosure Requirements if You’re a Smaller Reporting Company or Emerging Growth Company
What to know about pay vs. performance and other disclosure rules if your company is an SRC or an EGC.
What Growth-Stage Biotech and Pharma Companies Need to Know About the PvP Rules
While the rules are clear on what needs to be done to comply with pay vs. performance disclosure, there are unique challenges for biotech and pharma.